Global Level Quantification of Histone Post-Translational Modifications in a 3D Cell Culture Model of Hepatic Tissue
May 5th, 2022
This protocol outlines how a three-dimensional cell culture system can be used to model, treat, and analyze chromatin modifications in a near-physiological state.
Overview
This study presents a three-dimensional cell culture system to model and analyze chromatin modifications, particularly focusing on post-translational modifications (PTMs) associated with histones in a physiologically relevant manner. The method enables the examination of histone PTMs through a comprehensive liquid chromatography mass spectrometry approach, revealing significant insights into the dynamics of chromatin related to disease states.
Key Study Components
Research Area
- Chromatin dynamics
- Post-translational modifications
- Cell culture technologies
Background
- Chromatin dynamics are crucial in mediating diseases like cancer and aging.
- Standard assays often limit the analysis of histone PTMs to single modifications at a time.
- This study aims to advance the understanding of chromatin modifications through innovative experimental setups.
Methods Used
- Three-dimensional cell culture for spheroid formation.
- C3A hepatocytes as the biological system.
- Liquid chromatography mass spectrometry for measuring multiple histone PTMs.
Main Results
- The treatment of spheroids with sodium butyrate increased acetylation levels.
- Sodium succinate treatment enhanced histone succinylation.
- The study identified intricate patterns of histone modifications under specified conditions.
Conclusions
- This protocol provides a reliable model to study chromatin changes in 3D cultures.
- It contributes to the broader understanding of how histone modifications relate to various biological processes and diseases.
Frequently Asked Questions
Executive Industry Relevance
Quantitative profiling of histone post-translational modifications (PTMs) in physiologically relevant 3D hepatic models addresses a critical gap in chromatin biology for drug discovery. This workflow enables high-content, multiplexed analysis of chromatin states, supporting predictive confidence in target validation and mechanistic de-risking for epigenetic and metabolic disease programs. Integration of mass spectrometry-based PTM quantification in 3D systems enhances translational continuity from discovery to preclinical research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of chromatin regulatory pathways in a tissue-relevant context.
- Supports functional validation of epigenetic targets by quantifying global and combinatorial histone PTMs.
- Facilitates mechanistic de-risking by linking compound treatment to specific chromatin modifications.
- Improves predictive confidence for advancing epigenetic modulators in the portfolio.
Screening & Assay Development
- Establishes reproducible 3D spheroid models for robust chromatin modification assays.
- Delivers quantitative, multiplexed PTM readouts suitable for screening compound effects on chromatin state.
- Enables assay standardization and reproducibility across experimental runs and conditions.
- Prepares validated biological systems for downstream high-content screening workflows.
Translational & Preclinical Research
- Aligns chromatin modification profiles with disease-relevant hepatic tissue models.
- Supports continuity from in vitro discovery to preclinical validation of epigenetic mechanisms.
- Provides translational biomarker insights by mapping PTM patterns to functional chromatin states.
- De-risks advancement decisions by linking molecular changes to physiologically relevant endpoints.
Pipeline & Workflow Integration
This method bridges early discovery and preclinical research by enabling quantitative chromatin analysis in 3D hepatic models, supporting lead identification and mechanistic validation.
- Discovery Biology: Quantifies global and combinatorial histone PTMs to clarify chromatin regulatory mechanisms.
- Screening: Provides reproducible, multiplexed PTM measurements for compound evaluation in 3D systems.
- Analytics: Delivers high-content LC-MS/MS data and computational analysis of PTM abundance and patterns.
- Translational Research: Aligns in vitro chromatin states with disease-relevant tissue models for biomarker development.
- Enterprise Reuse: Offers a scalable workflow adaptable to other solid tissue models and epigenetic targets.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in chromatin-targeted programs.
- Operational Value: Standardizes 3D culture and PTM quantification for reproducible, scalable workflows.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio advancement.
- Portfolio Impact: Supports risk-adjusted prioritization of epigenetic and metabolic disease assets.
Implementation Considerations
- Requires expertise in 3D cell culture, histone extraction, and LC-MS/MS analysis.
- Demands access to high-resolution mass spectrometry and computational data processing pipelines.
- Necessitates cross-team standardization of spheroid formation and sample handling protocols.
- Adaptation to other tissue models may require optimization of culture and extraction conditions.
- Sample handling and desalting steps are critical to avoid loss or contamination, as noted in the protocol.
Biopharma FAQs
Chapters in this video
0:04
Introduction
0:53
Preparation of the 3D Culture System
2:20
Growth of Spheroids in the Bioreactor
3:15
Histone Extraction
4:27
The First Round of Derivatization
5:03
Desalting, Sample Cleanup, and Sample Preparation for LC-MS/MS
6:08
Results: Identification and Quantification of Histone Post-Translational Modifications
7:37
Conclusion
